SCHEDULE 13G/AAccepted Mar 5, 6:08 AM ET
ArriVent BioPharma, Inc. SCHEDULE 13G/A
Accepted (ET)
6:08 AM
Mar 5, 2026
Filed
Mar 5, 2026
Documents
2
Size
29.3 KB
Summary
Summary not available
This filing does not have a written summary yet. You can still open the original filing and its exhibits.